VALUE IN HEALTH

Scope & Guideline

Driving Change in Public Health Through Scholarly Excellence

Introduction

Welcome to your portal for understanding VALUE IN HEALTH, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1098-3015
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1998 to 2024
AbbreviationVALUE HEALTH / Value Health
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

VALUE IN HEALTH focuses on advancing knowledge in health economics and outcomes research, emphasizing the value of health technologies and treatments. The journal publishes research that informs decision-making in healthcare policy, clinical practice, and pharmaceutical development.
  1. Health Economic Evaluations:
    The journal includes studies that assess the cost-effectiveness, budget impact, and value of health interventions, providing insights into economic implications for healthcare systems.
  2. Patient-Reported Outcomes:
    Papers often explore patient-reported outcomes (PROs) and quality of life measures, highlighting the importance of patient perspectives in evaluating health interventions.
  3. Real-World Evidence (RWE):
    A significant focus is on real-world data and its application in health technology assessments, offering insights into treatment patterns and outcomes outside of clinical trials.
  4. Health Policy and Decision-Making:
    The journal addresses health policy implications, including how economic evaluations can guide reimbursement decisions and access to innovative therapies.
  5. Comparative Effectiveness Research:
    VALUE IN HEALTH publishes studies comparing the effectiveness of different health technologies and treatments, aiding stakeholders in making informed choices.
  6. Methodological Advances:
    The journal encourages methodological innovations in health economics, including statistical modeling techniques and frameworks for health technology assessment.
Recent publications in VALUE IN HEALTH reveal emerging trends and themes that reflect the evolving landscape of health economics and outcomes research. These trends highlight the journal's adaptability to current healthcare challenges and priorities.
  1. Integration of Artificial Intelligence (AI) in Health Economics:
    There is a growing trend of utilizing AI and machine learning techniques to enhance economic modeling, improve predictive analytics, and streamline the research process in health economics.
  2. Focus on Equity in Healthcare:
    Emerging research emphasizes health equity, exploring disparities in access to healthcare and treatment outcomes, particularly in marginalized communities.
  3. Patient Engagement and Experience:
    A rising number of studies are addressing patient engagement in health technology assessments, emphasizing the importance of incorporating patient preferences and experiences.
  4. Digital Health Interventions:
    The journal is increasingly publishing research on the economic evaluation of digital health technologies, reflecting the rapid advancement and adoption of telehealth and mobile health solutions.
  5. Long COVID and its Economic Impact:
    With the ongoing effects of the COVID-19 pandemic, there is an emerging focus on the long-term economic and health impacts of long COVID, including healthcare utilization and patient outcomes.
  6. Value-Based Care Models:
    The shift towards value-based care is reflected in the growing number of publications analyzing the cost-effectiveness and outcomes of value-based treatment approaches.

Declining or Waning

While VALUE IN HEALTH continues to thrive in various areas, certain themes appear to be waning in prominence, reflecting shifts in research focus and healthcare priorities.
  1. Traditional Cost-Effectiveness Analysis:
    There is a noticeable decline in studies focusing solely on traditional cost-effectiveness analysis without incorporating broader value frameworks or real-world applications.
  2. Pharmaceutical Pricing Strategies:
    Research centered on pharmaceutical pricing strategies has decreased, potentially due to increased scrutiny and regulatory changes surrounding drug pricing in various countries.
  3. Single-Arm Trials in Economic Evaluations:
    The use of single-arm trials for economic evaluations has become less frequent as the preference shifts towards more robust comparative effectiveness studies that utilize real-world data.
  4. Basic Health Technology Assessments:
    Basic assessments without a comprehensive value perspective are declining, as stakeholders increasingly seek integrated approaches that consider multiple dimensions of value.

Similar Journals

Contemporary Clinical Trials Communications

Fostering Dialogue and Discovery in Clinical Trials
Publisher: ELSEVIER INCISSN: Frequency:

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Drugs-Real World Outcomes

Transforming pharmacological research into practical solutions.
Publisher: SPRINGERNATUREISSN: 2199-1154Frequency: 4 issues/year

Drugs-Real World Outcomes, published by SPRINGERNATURE, is an influential open access journal dedicated to the dissemination of research concerning the real-world impact of pharmacological therapies. Since its inception in 2014, this journal has established a significant presence in the field of Pharmacology, evidenced by its classification in the Q2 quartile for 2023 and a Scopus rank of #141 out of 272 in the medical pharmacology category, placing it in the 48th percentile. The journal’s scope encompasses a diverse range of studies aimed at bridging the gap between clinical research and practical outcomes, making it an essential resource for researchers, healthcare professionals, and students alike. Located in Switzerland, Drugs-Real World Outcomes allows researchers unfettered access to vital data, enhancing knowledge translation and improving health care practices. As it continues to evolve, the journal remains committed to fostering high-quality research that informs and advances the field of pharmacological therapies.

Health Economics Review

Empowering decision-makers with robust economic evaluations.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

Expert Opinion on Orphan Drugs

Empowering voices in the orphan drug landscape.
Publisher: TAYLOR & FRANCIS LTDISSN: 2167-8707Frequency: 12 issues/year

Expert Opinion on Orphan Drugs is a pivotal academic journal published by Taylor & Francis Ltd, focusing on the burgeoning field of orphan drugs, which are often essential for treating rare diseases. As an integral source of insights and advancements from 2013 to 2024, this journal aims to bridge the gap between emerging scientific research and clinical application, providing a platform for authors to discuss pharmacological innovations and policy implications. With its ISSN 2167-8707, the journal has established a reputably rigorous editorial process and is indexed in Scopus, showcasing its relevance with ranks in various pharmacology and health policy disciplines. Though currently not an open-access journal, it endeavors to deliver high-quality articles that are vital for researchers, healthcare professionals, and policy makers aiming to navigate the complexities and challenges in the orphan drug landscape. It is categorized in Q4 for Health Policy and Q3 for Pharmacology in recent evaluations, reflecting its accessible yet scholarly contributions to this niche area of medical research.

Pragmatic and Observational Research

Transforming Observations into Actionable Insights
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-7266Frequency: 1 issue/year

Pragmatic and Observational Research, published by DOVE MEDICAL PRESS LTD, is a distinguished open-access journal that has been advancing knowledge in the fields of clinical practices and epidemiological studies since its inception in 2010. With an ISSN of 1179-7266, this journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality research that influences real-world health outcomes. Although the journal does not currently have an HIndex or Scopus ranking, its commitment to open access ensures that all articles are readily available to a global audience, facilitating broad engagement and collaboration. The journal focuses on pragmatic and observational methodologies, emphasizing studies that inform evidence-based practices in health care, thereby playing a crucial role in aligning research with practical health challenges. By contributing to the understanding of health interventions and observational data, Pragmatic and Observational Research continues to uphold its mission of improving health care through rigorous research.

JOURNAL OF HEALTH ECONOMICS

Elevating Health Systems through Rigorous Economic Analysis
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Exploring the impact of technology on healthcare excellence.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0266-4623Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE is a leading academic journal published by Cambridge University Press, specializing in the critical evaluation of healthcare technologies and their impact on health policy. Established in 1970, it has gained recognition within the field, currently holding a prestigious Q2 ranking in Health Policy, with a commendable position of #89 out of 310 in the Scopus rankings, placing it in the 71st percentile. The journal serves as an essential platform for researchers, professionals, and students interested in the intersection of technology and health care, facilitating the dissemination of innovative research findings and practical assessments that inform policy-making and improve health outcomes. With a focus on advancing knowledge from 1985 to 2024, the journal's content remains relevant and impactful. Though not open access, it offers subscription-based access to a wealth of articles that contribute to shaping the future of healthcare technology assessment.

Journal of the National Comprehensive Cancer Network

Elevating Cancer Care: Insights and Innovations for Tomorrow
Publisher: HARBORSIDE PRESSISSN: 1540-1405Frequency: 15 issues/year

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Applied Health Economics and Health Policy

Innovating health solutions through economic evaluation.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Farmeconomia-Health Economics and Therapeutic Pathways

Innovative insights at the intersection of health and economics.
Publisher: SEED MEDICAL PUBLISHERSISSN: 1721-6915Frequency: 1 issue/year

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.